ISIS Pharmaceuticals (ISIS) CEO Says Not for Sale

On CNBC this morning, when asked about a rumors of a takeover, ISIS Pharmaceuticals Inc. (Nasdaq: ISIS) CEO said they are not for sale at this price. NOTE: Stock up 38% pre-open after blockbuster news on cholesterol lowering drug.